Net Cash Provided by (Used in) Financing Activities in USD of UTAH MEDICAL PRODUCTS INC from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
UTAH MEDICAL PRODUCTS INC quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • UTAH MEDICAL PRODUCTS INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was -$4.24M, a 6.4% decline year-over-year.
  • UTAH MEDICAL PRODUCTS INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$23.8M, a 472% decline from 2023.
  • UTAH MEDICAL PRODUCTS INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$4.17M, a 24.1% increase from 2022.
  • UTAH MEDICAL PRODUCTS INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$5.48M, a 49.7% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

UTAH MEDICAL PRODUCTS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$4.24M -$255K -6.4% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q1 2024 -$3.98M -$2.93M -280% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q1 2023 -$1.05M -$1.07M -5621% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q1 2022 $19K +$968K 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023
Q1 2021 -$949K +$6.47M +87.2% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q1 2020 -$7.42M -$6.49M -698% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q1 2019 -$930K -$72K -8.39% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020
Q1 2018 -$858K -$911K -1719% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q1 2017 $53K -$95K -64.2% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q1 2016 $148K +$4.84M 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017
Q1 2015 -$4.69M -$4M -576% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016
Q1 2014 -$694K -$150K -27.6% 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015
Q1 2013 -$544K +$1.28M +70.2% 01 Jan 2013 31 Mar 2013 10-Q 07 May 2014
Q1 2012 -$1.82M -$28.7M -107% 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013
Q1 2011 $26.8M 01 Jan 2011 31 Mar 2011 10-Q 09 May 2012

UTAH MEDICAL PRODUCTS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$23.8M -$19.7M -472% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025
2023 -$4.17M +$1.32M +24.1% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025
2022 -$5.48M +$5.42M +49.7% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2025
2021 -$10.9M -$171K -1.59% 01 Jan 2021 31 Dec 2021 10-K 26 Mar 2024
2020 -$10.7M -$6.51M -154% 01 Jan 2020 31 Dec 2020 10-K/A 28 Mar 2023
2019 -$4.23M +$550K +11.5% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2022
2018 -$4.78M -$2.12M -80.1% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2021
2017 -$2.65M +$3.69M +58.2% 01 Jan 2017 31 Dec 2017 10-K 16 Mar 2020
2016 -$6.34M +$2.55M +28.7% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019
2015 -$8.89M -$630K -7.63% 01 Jan 2015 31 Dec 2015 10-K 06 Mar 2018
2014 -$8.26M -$1.66M -25.2% 01 Jan 2014 31 Dec 2014 10-K 08 Mar 2017
2013 -$6.6M +$4.57M +40.9% 01 Jan 2013 31 Dec 2013 10-K 10 Mar 2016
2012 -$11.2M -$29.2M -162% 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015
2011 $18.1M +$24.5M 01 Jan 2011 31 Dec 2011 10-K 12 Mar 2014
2010 -$6.42M 01 Jan 2010 31 Dec 2010 10-K 07 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.